Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06379438
Other study ID # 06/16022018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 5, 2018
Est. completion date March 8, 2019

Study information

Verified date April 2024
Source Yuzuncu Yil University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The search for methods that can shorten the treatment process of aphthous ulcers, the etiology of which is not fully understood, continues. The aim of this study was to determine whether photodynamic therapy (PDT) is a clinically effective alternative in the treatment of oral aphthous ulcers.


Description:

After sample size calculation, photodynamic therapy and control groups were formed with 15 patients with aphthous ulcer in each group. Laser therapy with indocyanine green was applied to the photodynamic therapy group on the day they were admitted to the clinic. No treatment was performed in the control group and only follow-up was performed. Lesion diameters, pain intensity and degree of improvement at the end of 1 week were recorded in all patients.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date March 8, 2019
Est. primary completion date March 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - ASA-1 patients without any systemic disease, - With a history of canker sores not exceeding 2 days, - Not taking any antibiotics or anti-inflammatory drugs. Exclusion Criteria: - Laser therapy contraindicated, - Pregnancy, - Smoking habbit, - Poor oral hygiene, - Patients under 18 years of age

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
Photodynamic therapy (indocyanine green+laser)
Photodynamic therapy with indocyanine green

Locations

Country Name City State
Turkey Yuzuncu Yil University Van Merkez

Sponsors (1)

Lead Sponsor Collaborator
Yuzuncu Yil University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ulcer wound healing with diameter measurement Lesion diameters were measured with a elastic ruler and the healing rate of the lesion was monitored. One week (preoperatively and on postoperative days 3, 5 and 7 )
Primary Level of recovery A 3-point scale was used. Grade 1 represents "complete recovery", Grade 2 represents "moderate recovery", Grade 3 represents "little recovery". Postoperatively 7 th day
Secondary Pain evaluation with Visual Analogue Scale For lesion-related pain follow-up, patients in the PDT group were asked to score the pain they felt on VAS on preoperative, 1st, 3rd, 5th and 7th days. VAS measurements of the patients in the control group were made on days 1, 3, 5 and 7. One week
See also
  Status Clinical Trial Phase
Completed NCT03239834 - Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Not yet recruiting NCT04989049 - Therapeutic Effect of Folic Acid in Healing of Oral Ulcers Early Phase 1
Withdrawn NCT02769494 - The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer Phase 3
Completed NCT05413096 - Combination of Diclofenac Potassium and Propolis in the Therapy of Oral Aphthosis Early Phase 1
Completed NCT03633292 - Aloe Vera and Chlorhexidine Against Traumatic Oral Ulcers Phase 4
Completed NCT00333749 - The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases Phase 1
Recruiting NCT04710888 - Basil Extract (Ocimum Basilicum) in the Management of Recurrent Aphthous Stomatitis Phase 2
Completed NCT05147376 - Effectiveness of a Curcumin Mouthwash in Preventing Traumatic Ulcers in Patients With Fixed Orthodontic Appliances Early Phase 1
Completed NCT04383236 - Probiotic Lozenges for Treatment of Recurrent Aphthous Stomatitis N/A
Completed NCT03167632 - Oral Ulcer Prevalence: Hospital-based Cross-sectional Study N/A
Enrolling by invitation NCT05288478 - Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa. Phase 2
Recruiting NCT05449548 - Lenalidomide in the Treatment of Mucosal Behçet's Syndrome N/A
Completed NCT05032248 - Uses of Tacrolimus in Behcet Disease N/A